The eyePlate is intended to manage intraocular pressure in glaucoma patients where medically controlled glaucoma or filtering surgery have failed or are likely to fail, such as, but not limited to, neovascular glaucoma, aphakic/pseudophakic glaucoma, uveitic glaucoma, congenital glaucoma, etc.

Conjunctivitis, corneal ulcers, endophthalmitis, orbital cellulitis, bacteremia or septicemia, active scleritis, active uveitis, scleral buckle, rectus muscle surgery.

The eyeWatch system is indicated for patients suffering from glaucoma where medical and/or conventional surgical treatments have failed. The eyeWatch system is intended to drain aqueous humor from the anterior chamber to the subconjunctival space and to regulate non-surgically the intraocular pressure during the early post-operative period.

The implantation of the eyeWatch implant is contraindicated if one or more of the following conditions exist:

• Diagnosis of angle-closure glaucoma, neovascular glaucoma.
• Patient with ocular malformations such as microphthalmia.
• Patient with corneal opacifications or irregularities that may interfere with IOP measurements.
• History of previous corneal transplant surgery.
• Patient with concurrent inflammatory/infective eye disorder.